Beta Secretase Inhibitors For Alzheimer's Disease

With each new amyloid-targeting treatment for Alzheimer's disease that has been developed, there has been a corresponding concern about antibodies targeting amyloid-β peptide (Aβ) producing inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.  read more

Read the whole article on

More from